Evidence map›Paper›PMID 37931753›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2024

The Banff 2022 Kidney Meeting Work Plan: Data-driven refinement of the Banff Classification for renal allografts.

Candice Roufosse, Maarten Naesens, Mark Haas, Carmen Lefaucheur, Roslyn B Mannon, Marjan Afrouzian, Nada Alachkar, Olivier Aubert, Serena M Bagnasco, Ibrahim Batal and 43 more

Open access · hybridAbstract read
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
11.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Antibody-mediated rejection in ABO-incompatible kidney transplantation.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Findings and significance of early follow-up biopsies after treatment of acute rejection in kidney transplant recipients.Transplant international : official journal of the European Society for Organ Transplantation · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Late Allograft Loss and Contemporary Cardiorenal Metabolic Therapies.Journal of the American Society of Nephrology : JASN · 2025
    Review
  16. Article
  17. Review
  18. Article
  19. What makes the kidney so tolerant?The Journal of clinical investigation · 2024
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

53 authors at 20 institutions in 10 countries.

Candice RoufosseDepartment of Immunology and Inflammation, Faculty Medicine, Imperial College London, London, UK. Electronic address: c.roufosse@imperial.ac.uk.
Maarten NaesensDepartment of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium. Electronic address: maarten.naesens@kuleuven.be.
Mark HaasDepartment of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Carmen LefaucheurUniversité Paris Cité, INSERM, PARCC, Paris Institute for Transplantation and Organ Regeneration, France & Department of Nephrology and Transplantation, Saint-Louis Hospital, Paris, France.
Roslyn B MannonDepartment of Internal Medicine, Division of Nephrology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Marjan AfrouzianDepartment of Pathology, University of Texas Medical Branch at Galveston, Texas, USA.
Nada AlachkarDepartment of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Olivier AubertUniversité Paris Cité, INSERM, PARCC, Paris Institute for Transplantation and Organ Regeneration, France & Department of Transplantation, Necker Hospital, Paris, France.
Serena M BagnascoDepartment of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Ibrahim BatalPathology & Cell Biology, Columbia University Irving Medical Center, New York, USA.
Chris O C BellamyDivision of Pathology, University of Edinburgh, Scotland.
Verena BroeckerDepartment of Clinical Pathology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Klemens BuddeDepartment of Nephrology, Charité Universitätsmedizin, Berlin, Germany.
Marian Clahsen-Van GroningenDepartment of Pathology and Clinical Bioinformatics, Erasmus University Center Rotterdam, Rotterdam, Netherlands; Institute of Experimental Medicine and Systems Biology, RWTH Aachen University, Aachen, Germany.
Shana M ColeyTransplant Translational Research, Arkana Laboratories, Arkansas, USA.
Lynn D CornellDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Darshana DadhaniaDepartment Medicine, Weill Cornell Medical College of Cornell University, New York, New York, USA.
Anthony J DemetrisUPMC Hepatic and Transplantation Pathology, Pittsburg, Pennsylvania, USA.
Gunilla EineckeDepartment of Nephrology and Rheumatology, University Medical Center Göttingen, Germany.
Alton B FarrisDepartment of Pathology and Laboratory Medicine, Emory University, USA.
Agnes B FogoDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
John FriedewaldComprehensive Transplant Center, Northwestern University, USA.
Ian W GibsonDepartment of Pathology, University of Manitoba, Winnipeg, Canada.
Catherine HorsfieldDept of Histopathology, Guy's & St Thomas' Hospital, London, UK.
Edmund HuangDepartment of Medicine, Division of Nephrology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Syed A HusainDivision of Nephrology, Columbia University, New York, New York, USA.
Annette M JacksonDepartment of Surgery, Duke University, Durham, North Carolina, USA.
Jesper KersDepartment of Pathology, Leiden University Medical Center, Netherlands; Department of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Željko KikićDepartment of Urology, Medical University of Vienna, Vienna, Austria.
Amanda KleinCritical Path Institute, Tucson, Arizona, USA.
Nicolas KozakowskiDepartment of Pathology, Medical University of Vienna, Vienna, Austria.
Helen LiapisLudwig Maximillian University Munich, Nephrology Center, Germany.
Massima MangiolaTransplant Institute, NYU Langone Health, New York, USA.
Robert A MontgomeryNYU Langone Transplant Institute, New York, USA.
Brian NankinvellDepartment of Renal Medicine, Westmead Hospital, Westmead, New South Wales, Australia.
Desley A H NeilDepartment of Cellular Pathology, Queen Elizabeth Hospital Birmingham and Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
Peter NickersonDepartment of Medicine and Department of Immunology, University of Manitoba, Winnipeg, Canada.
Marion RabantPathology department, Necker-Enfants Malades Hospital, Paris, France.
Parmjeet RandhawaPathology, Thomas E. Starzl Transplant Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Leonardo V RiellaDepartment of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Ivy RosalesImmunopathology Research Laboratory, Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Virginie RoyalMaisonneuve-Rosemont Hospital, University of Montreal, Quebec, Canada.
Ruth Sapir-PichhadzeDivision of Nephrology & Multiorgan Transplant Program, McGill University, Montreal, Quebec, Canada.
Pinaki SarderDepartment of Medicine-Quantitative Health, University of Florida College of Medicine, Florida, USA.
Minnie SarwalDivision of MultiOrgan Transplantation, UCSF, San Francisco, California, USA.
Carrie SchinstockDepartment of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
Mark StegallDepartment Transplantation Surgery, Mayo Clinic, Rochester, Massachusetts, USA.
Kim SolezDepartment of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Canada.
Jeroen van der LaakDepartment of Pathology, Radboud University Medical Center, Netherlands.
Chris WiebeDepartment of Medicine and Department of Immunology, University of Manitoba, Winnipeg, Canada.
Robert B ColvinDepartment of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Alexandre LoupyUniversité Paris Cité, INSERM, PARCC, Paris Institute for Transplantation and Organ Regeneration, France & Department of Transplantation, Necker Hospital, Paris, France.
Michael MengelDepartment of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Canada.
Mayo Clinic · USUniversity of Manitoba · CACedars-Sinai Medical Center · USHarvard University · USHôpital Necker-Enfants Malades · FRJohns Hopkins University · USMedical University of Vienna · ATMiami Transplant Institute · USUniversity of Alberta · CAArkana Laboratories · USCharité - Universitätsmedizin Berlin · DEColumbia University · USColumbia University Irving Medical Center · USCornell University · USCritical Path Institute · USDuke University · USEmory University · USHôpital Maisonneuve-Rosemont · CAImperial College London · GBInserm · FR

Funding

Computational Imaging of Renal Structures for Diagnosing DiabeticNephropathyR01DK114485 · NIDDK · UNIVERSITY OF FLORIDA · PI Michael Thomas Eadon, Avi Z Rosenberg · 2018 to 2026
$4.7M
Computational Image Analysis of Renal Transplant Biopsies to Predict Graft OutcomeR01DK129541 · NIDDK · UNIVERSITY OF FLORIDA · PI Kuang-Yu Jen, Pinaki Sarder · 2023 to 2026
$2.8M
NIDDK NIH HHS R01 DK114485NIDDK NIH HHS R01 DK129541
6 · The paper itself

Abstract

The XVIth Banff Meeting for Allograft Pathology was held in Banff, Alberta, Canada, from September 19 to 23, 2022, as a joint meeting with the Canadian Society of Transplantation. In addition to a key focus on the impact of microvascular inflammation and biopsy-based transcript analysis on the Banff Classification, further sessions were devoted to other aspects of kidney transplant pathology, in particular T cell-mediated rejection, activity and chronicity indices, digital pathology, xenotransplantation, clinical trials, and surrogate endpoints. Although the output of these sessions has not led to any changes in the classification, the key role of Banff Working Groups in phrasing unanswered questions, and coordinating and disseminating results of investigations addressing these unanswered questions was emphasized. This paper summarizes the key Banff Meeting 2022 sessions not covered in the Banff Kidney Meeting 2022 Report paper and also provides an update on other Banff Working Group activities relevant to kidney allografts.

Indexed as

Kidney TransplantationAllograftsCanadaGraft RejectionKidneyallograftBanffclassificationpathologyworking groupswork plan

Identifiers

PMID37931753
PMCPMC11135910
OpenAlexW4388336370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.